Impact of newborn screening on severe combined immunodeficiency survival: results from a 36-year longitudinal study

Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium – The Lancet (link to abstract – $ for full-text)

News Release: Newborn screening facilitates early identification of infants with severe combined immunodeficiency – NIH/National Institute of Allergy and Infectious Diseases/News Medical

Commentary on Twitter

Findings from a 36-year longitudinal study provide direct evidence that newborn screening for SCID has been the primary driver of improved survival in new-born babies in the USA and Canada since 2010.

Read the full article: https://t.co/TAAcPztpF9 pic.twitter.com/cOxvNNJmb9

— The Lancet (@TheLancet) July 12, 2023